150 related articles for article (PubMed ID: 16288898)
1. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
Machado AP; Pinto RS; Moysés ZP; Nakandakare ER; Quintão EC; Passarelli M
Int J Biochem Cell Biol; 2006 Mar; 38(3):392-403. PubMed ID: 16288898
[TBL] [Abstract][Full Text] [Related]
2. Metformin restores impaired HDL-mediated cholesterol efflux due to glycation.
Matsuki K; Tamasawa N; Yamashita M; Tanabe J; Murakami H; Matsui J; Imaizumi T; Satoh K; Suda T
Atherosclerosis; 2009 Oct; 206(2):434-8. PubMed ID: 19376519
[TBL] [Abstract][Full Text] [Related]
3. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Kiho T; Kato M; Usui S; Hirano K
Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.
Tuttle KR; Anderberg RJ; Cooney SK; Meek RL
Am J Nephrol; 2009; 29(3):171-80. PubMed ID: 18781061
[TBL] [Abstract][Full Text] [Related]
5. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
Zhou H; Tan KC; Shiu SW; Wong Y
Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
Hodgkinson CP; Laxton RC; Patel K; Ye S
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
[TBL] [Abstract][Full Text] [Related]
7. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.
Schurman L; McCarthy AD; Sedlinsky C; Gangoiti MV; Arnol V; Bruzzone L; Cortizo AM
Exp Clin Endocrinol Diabetes; 2008 Jun; 116(6):333-40. PubMed ID: 18273753
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.
Reddy VP; Beyaz A
Drug Discov Today; 2006 Jul; 11(13-14):646-54. PubMed ID: 16793534
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
Kim HY; Okamoto T; Yokozawa T
J Ethnopharmacol; 2009 Jul; 124(2):263-9. PubMed ID: 19397970
[TBL] [Abstract][Full Text] [Related]
10. AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages.
Iborra RT; Machado-Lima A; Okuda LS; Pinto PR; Nakandakare ER; Machado UF; Correa-Giannella ML; Pickford R; Woods T; Brimble MA; Rye KA; Lu R; Yokoyama S; Passarelli M
J Diabetes Complications; 2018 Jan; 32(1):1-10. PubMed ID: 29097054
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal.
Wang X; Chang T; Jiang B; Desai K; Wu L
Am J Hypertens; 2007 Jun; 20(6):629-36. PubMed ID: 17531919
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
Wang X; Jia X; Chang T; Desai K; Wu L
J Hypertens; 2008 Apr; 26(4):765-72. PubMed ID: 18327087
[TBL] [Abstract][Full Text] [Related]
14. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Booth AA; Khalifah RG; Hudson BG
Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
[TBL] [Abstract][Full Text] [Related]
15. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
16. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
17. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
18. Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus.
Passarelli M; Shimabukuro AF; Catanozi S; Nakandakare ER; Rocha JC; Carrilho AJ; Quintão EC
Clin Chim Acta; 2000 Nov; 301(1-2):119-34. PubMed ID: 11020467
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
20. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products.
Mera K; Nagai R; Haraguchi N; Fujiwara Y; Araki T; Sakata N; Otagiri M
Free Radic Res; 2007 Jun; 41(6):713-8. PubMed ID: 17516244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
